Page last updated: 2024-10-26

etilefrine and Neurally Mediated Faint

etilefrine has been researched along with Neurally Mediated Faint in 5 studies

Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.

Research Excerpts

ExcerptRelevanceReference
"Etilefrine is an alpha-agonist agent with a potent vasoconstrictor effect, which is potentially useful in preventing vasovagal syncope by reducing venous pooling and/or by counteracting reflex arteriolar vasodilatation."2.69Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. ( Alboni, P; Brignole, M; Giani, P; Menozzi, C; Moya, A; Raviele, A; Sutton, R, 1999)
"Many drugs have been used for the treatment of vasovagal syncope (beta-blockers, disopyramide, scopolamine, clonidine, theophylline, fludrocortisone, ephedrine, dihydroergotamine, etilefrine, midodrine, clonidine, serotonin reuptake inhibitors, enalapril)."2.42Randomized clinical trials of neurally mediated syncope. ( Brignole, M, 2003)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liao, Y1
Li, X1
Zhang, Y1
Chen, S1
Tang, C1
Du, J1
Brignole, M2
Di Girolamo, E1
Di Iorio, C1
Sabatini, P1
Leonzio, L1
Barsotti, A1
Raviele, A1
Sutton, R1
Alboni, P1
Giani, P1
Menozzi, C1
Moya, A1
Ammirati, F1
Colivicchi, F1
Santini, M1

Reviews

2 reviews available for etilefrine and Neurally Mediated Faint

ArticleYear
alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data.
    Acta paediatrica (Oslo, Norway : 1992), 2009, Volume: 98, Issue:7

    Topics: Adrenergic alpha-Agonists; Etilefrine; Humans; Midodrine; Outcome Assessment, Health Care; Randomize

2009
Randomized clinical trials of neurally mediated syncope.
    Journal of cardiovascular electrophysiology, 2003, Volume: 14, Issue:9 Suppl

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Cardiac Pacing, Artificial; Dou

2003

Trials

3 trials available for etilefrine and Neurally Mediated Faint

ArticleYear
[Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
    Cardiologia (Rome, Italy), 1998, Volume: 43, Issue:8

    Topics: Adolescent; Adult; Aged; Etilefrine; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged;

1998
Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
    Circulation, 1999, Mar-23, Volume: 99, Issue:11

    Topics: Adrenergic alpha-Agonists; Adult; Cohort Studies; Disease-Free Survival; Double-Blind Method; Etilef

1999
Effects of intravenous etilefrine in neurocardiogenic syncope induced by head-up tilt testing.
    The American journal of cardiology, 2000, Aug-15, Volume: 86, Issue:4

    Topics: Adrenergic Agonists; Adult; Etilefrine; Female; Hemodynamics; Humans; Injections, Intravenous; Male;

2000